Crossmark

The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

Crossref DOI link: https://doi.org/10.1038/s41598-021-92887-5

Published Online: 2021-06-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pape, Sarah E.

al Janabi, Tamara

Ashton, Nicholas J.

Hye, Abdul

Sheehan, Rory

Gallagher, Paul

Knight, Bernice

Prins, Anne-Marije

Courtenay, Ken

Jordanova, Vesna

Thomas, Bini

Perumal, Nagarajan

Forbes, Craig

Hassiotis, Angela

Strydom, Andre
Funding

Funding for this research was provided by:

Alzheimer’s Society Fellowship (AS-CP-18-0020)

NIHR

Jerome Lejeune Foundation - Horizon21

Medical Research Council (MRC S011277/1, MR/S005145/1 (from Centres of Excellence in Neurodegeneration research) and MR/R024901/1 (from JPND))

National Institute for Health Research networks

Wellcome Trust Strategic Award (098330/Z/12/Z)
License Information

Text and Data Mining valid from 2021-06-29

Version of Record valid from 2021-06-29
More Information

Article History

Received: 22 January 2021

Accepted: 17 June 2021

First Online: 29 June 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below